Your browser doesn't support javascript.
loading
Biomarkers for the prediction of heart failure and cardiovascular events in patients with type 2 diabetes: a position statement from the Heart Failure Association of the European Society of Cardiology.
Seferovic, Peter; Farmakis, Dimitrios; Bayes-Genis, Antoni; Ben Gal, Tuvia; Böhm, Michael; Chioncel, Ovidiu; Ferrari, Roberto; Filippatos, Gerasimos; Hill, Loreena; Jankowska, Ewa; Lainscak, Mitja; Lopatin, Yuri; Lund, Lars H; Mebazaa, Alexandre; Metra, Marco; Moura, Brenda; Rosano, Giuseppe; Thum, Thomas; Voors, Adriaan; Coats, Andrew J S.
Afiliação
  • Seferovic P; Faculty of Medicine, University of Belgrade Belgrade, Serbia and Serbian Academy of Sciences and Arts, Belgrade, Serbia.
  • Farmakis D; University of Belgrade Belgrade, Belgrade, Serbia.
  • Bayes-Genis A; University of Cyprus Medical School, Nicosia, Cyprus.
  • Ben Gal T; Heart Institute, Hospital Universitari German Trias i Pujol, Badalona, Spain.
  • Böhm M; Department of Medicine, Universitat Autónoma de Barcelona, Barcelona, Spain.
  • Chioncel O; CIBERCV, Instituto de Salud, Madrid, Spain.
  • Ferrari R; Heart Failure Unit, Cardiology Department, Rabin Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Filippatos G; Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Saarland University, Homburg, Germany.
  • Hill L; Emergency Institute for Cardiovascular Diseases 'Prof. C.C. Iliescu', Bucharest, and University of Medicine Carol Davila, Bucharest, Romania.
  • Jankowska E; Maria Cecilia Hospital, GVM Care & Research, Ravenna, Italy.
  • Lainscak M; Laboratory for Technologies of Advanced Therapies (LTTA), Department of Translational Medicine, University of Ferrara, Ferrara, Italy.
  • Lopatin Y; Second Department of Cardiology, Athens University Hospital Attikon, National and Kapodistrina University of Athens Medical School, Athens, Greece.
  • Lund LH; School of Nursing and Midwifery, Queen's University, Belfast, UK.
  • Mebazaa A; Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.
  • Metra M; Centre for Heart Diseases, University Hospital, Wroclaw, Poland.
  • Moura B; Division of Cardiology, General Hospital Murska Sobota, Murska Sobota, Slovenia, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
  • Rosano G; Volgograd State Medical University, Regional Cardiology Centre Volgograd, Volgograd, Russian Federation.
  • Thum T; Department of Medicine, Karolinska Institutet, and Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.
  • Voors A; INSERM UMR-S 942, Paris, France; Department of Anesthesiology and Critical Care Medicine, St. Louis and Lariboisère University Hospitals, Paris, France.
  • Coats AJS; Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
Eur J Heart Fail ; 24(7): 1162-1170, 2022 07.
Article em En | MEDLINE | ID: mdl-35703329

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cardiologia / Diabetes Mellitus Tipo 2 / Insuficiência Cardíaca Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cardiologia / Diabetes Mellitus Tipo 2 / Insuficiência Cardíaca Idioma: En Ano de publicação: 2022 Tipo de documento: Article